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Summary 
In this paper, we present a novel biochemical sensing device which is monitoring lithium level from 
saliva for a non-invasive measurement. According to the American Psychiatric Association (APA) 2002 
guidelines for treating bipolar disorder, the first-line therapy for bipolar patients with severe mania or 
mixed episodes is an antipsychotic medication combined with either lithium or the anticonvulsant 
Depakote1. Lithium (brand names Eskalith, Lithobid, Lithonate, and Lithotabs) is the most widely used 
and studied medication for treating bipolar disorder for reducing the severity and frequency of mania 
depression 2 . But it is also a very difficult and potentially dangerous drug for patients. Lithium's 
therapeutic dose is uncomfortably close to its toxic dose, meaning it is rather easy to take too much 
lithium by mistake and become poisoned. Therefore, patients need to have regular tests with blood serum 
to monitor the levels of lithium based medication.  
This paper presents part of our work in developing a low cost, non-invasive portable healthcare 
technology to put more control into the hands of patients so that the earliest signs of problems can be 
detected and corrected by monitoring the drug level from the saliva. 
Motivation 
A very sensitive analytical method was investigated for the spectrofluorimetric determination of lithium 
base on its reaction with 1,4-dihydroxyanthraquinone (Quinizarin)3. The fluorescence is measured at 620 
nm with an excitation wavelength of 590 nm. A portable biochemical device was developed to measure 
the intensity of fluorescence. The light source (λcenter = 590nm, 50mW) and photo detector (OPT101: 
Texas Instruments) were configured at 90 degree angle in the opaque cuvette holder as shown in Fig. 1. 
Results 
Prototype of portable device has been developed including photo detector for spectrofluorimetric sensing 
as shown in Figure 2. The receiver unit is connected with USB port of laptop/PC. Saliva sample was 
tested using portable device in order to validate the feasibility of saliva as a sample to detect lithium ions. 
According to the clinical tests, the salivary lithium concentration is 2.2 ~ 2.5 times higher than serum 
lithium with significant correlation factor.  Unstimulated saliva was collected and known concentration of 
Li+ was spiked into the saliva to prepare the Li+ doped saliva. Using lithium doped salivary sample, 
calibration was performed.  Results presented in Fig. 3 show calibrations obtained from different saliva 
samples collected on different days. Similar results were obtained with linear range of detection between 
0.25mM ~ 6.0 mM of Li+ and  R2=0.990.  When we consider the therapeutic range of lithium in serum is 
0.6 ~ 1.0 mM, the expected salivary lithium concentration would be higher than lithium in serum. Linear 
range of the proposed method covers sufficiently the therapeutic range of lithium drugs. 
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Figures 
 
Fig. 1: Schematic of the optical sensing 
module for the measurement of 
fluorescence. 
Fig. 2: Developed portable biochemical 
device for measuring the concentration of 
lithium in salivary sample.  
Fig. 3: Calibration results from Li+ doped saliva with portable device. 
y = 0.0051x + 14.309
R2 = 0.999
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